Agree with you. The contact info is very interesting. Seems to me Vibi and Canta have a winner.. Vibi with the nanotech to deliver Cantabios dj-1 protein to inhibit a-synuclein aggregation to stop early onset of Parkinson disease. As far as Cantabio being shady or a scam.. Definitely not. They worked with Purdue University and published novel studies demonstrating importance of dj-1 protein in the onset and pathology of Alzheimers and Parkinsons. Obviously the results of the studies were very successful hence the grant.. They did receive grant from Michael J Fox foundation. I thought that was years ago but actually just got grant few months ago. Here is a link from Purdue https://www.purdue.edu/newsroom/releases/2016/Q3/cantabio,-purdue-sign-agreement-to-investigate-targeting-of-dj-1-protein-for-treating-parkinsons-diseases.html And here is a link with a telling pdf https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.racap.com/media/TechAtlas/RACapital_Parkinsons_Disease_V2.pdf&ved=2ahUKEwiyqMbulZftAhUaTDABHXynDDUQFjADegQICBAB&usg=AOvVaw35GrMBnqB6CO-jDes6bEfc If you look on the right side about half way down you see Cantabios role in this (CB 101,102,201) from RA Capital. Great find S!! $VIBI$